Open access
Oct 2026
Shenling Qige Granules inhibit esophageal squamous cell carcinoma progression in TE-1 xenograft and cell-based models by modulating the DCN–TGF-β/Smad signaling axis
Shenling Qige Granules (SLQG), derived from the Qing Dynasty formula Qige San recorded in Yi Xue Xin Wu, has been used in clinical practice in China as an adjuvant traditional Chinese medicine preparation for esophageal squamous cell carcinoma (ESCC), but its molecular basis remains unclear. This study investigated the...
Zi-Hui Liu, Yi-Ting Gu, Huan-Fang Fan et al.
· PLoS ONE · 0 citations